go back

Ranibizumab (Susvimo) Sustained-Release Implant

New Mexico rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $91 · 10th–90th $91$910%50%100%$91Professionalmedian $79 · 10th–90th $79$910%20%40%90th$79$100.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$91.20
Median
$91.20
Typical High
$91.20
Aetna
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$91.20